IP Library Granted Patent US 11,098,313
Granted Patent B2
US 11,098,313 · App. 16/022,881 · Granted Aug 24, 2021

Replicative minicircle vectors with improved expression

Inventor: James A. Williams (Lincoln, NE)
Assignee: NATURE TECHNOLOGY CORPORATION
C12N15/79C12N15/63C12N15/64C12N15/67C12N15/85C12P19/34C12P21/00A61K48/00C12N2800/107C12N2800/24C12N2820/55C12N2830/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,098,313
App. No.
16/022,881
Granted
Aug 24, 2021
Kind
B2
Abstract

The present invention relates to the production and use of covalently closed circular (ccc) recombinant DNA molecules such as plasmids, cosmids, bacterial artificial chromosomes (BACs), bacteriophages, viral vectors and hybrids thereof, and more particularly to vector modifications that improve expression of said DNA molecules.

Claims (4)

1. A eukaryotic replicative minicircle expression vector comprising: i) a eukaryotic region sequence with 5′ and 3′ ends encoding a gene of interest and comprising an intron with a 5′ splice donor and a 3′ acceptor branch site, and a 3′ UTR, ii) a spacer region of less than 500 basepairs in length linking the 5′ and 3′ ends of the eukaryotic region sequences, iii) a bacterial replication origin positioned at a first location selected from the group consisting of within said spacer region, within said 3′ UTR and within said intron between the 5′ splice donor and the 3′ acceptor branch site, and iv) a RNA selectable marker positioned at a second location selected from the group consisting of within said spacer region, within said 3′ UTR and within said intron between the 5′ splice donor and the 3′ acceptor branch site, wherein the first location is different than the second location, wherein the bacterial replication origin is an R6K bacterial replication origin, and wherein the R6K bacterial replication origin has at least 95% sequence identity to the sequence of SEQ ID NO: 11.

2. The vector of claim 1 , wherein said RNA selectable marker is a functional RNA-OUT with at least 95% sequence identity to a sequence selected from the group consisting of SEQ ID NO: 20 and SEQ ID NO: 22.

3. The vector of claim 1 , wherein said RNA selectable marker is selected from the group consisting of an RNA-OUT selectable marker that encodes functional RNA-OUT RNA with at least 95% sequence identity to SEQ ID NO: 21, an RNAI selectable marker that encodes an RNAII regulating RNAI RNA with at least 95% sequence identity to SEQ ID NO: 33, an IncB RNAI selectable marker encoding an RNAII regulating RNAI RNA with at least 95% sequence identity to SEQ ID NO: 35 and a synthetic RNA selectable marker encoding an RNA selectable marker complement regulating RNA with at least 95% sequence identity to SEQ ID NO: 38.

4. The vector of claim 1 , wherein said intron with a 5′ splice donor and a 3′ acceptor branch site is a functional variant with at least 95% sequence identity to a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, and SEQ ID NO: 10.

Assignments (2)
MERGER Recorded Feb 22, 2023
From: NATURE TECHNOLOGY CORPORATION
To: ALDEVRON, L.L.C.
Reel/Frame 062770/0971 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2018
From: WILLIAMS, JAMES A.
To: NATURE TECHNOLOGY CORPORATION
Reel/Frame 046235/0868 →
Priority Claims (2)
WO PCT/US2013/000067 · Mar 14, 2013 · international
WO PCT/US2013/000068 · Mar 14, 2013 · international
Continuity (3)
Continuation 14432693
Provisional Application 61796765 · Nov 19, 2012
Related Publication 20180298393A1 · Oct 18, 2018
Cited By (2)
US 12,473,567 US 12,473,568